Table 1. Study population.
| Age (years) | 69.4 (11.4) |
| Gender (% males/females) | 74/46 (61.7/38.3) |
| Diabetes (%) | 41 (34.2) |
| Charlson’s comorbidity score | 6.1 (2.0) |
| Body mass index (Kg/m2) | 27.8 (4.7) |
| Lean body mass (Kg)* | 40.3 (9.9) |
| Fat mass (Kg)* | 23.9 (9.0) |
| Ratio intracellular/extracellular water* | 0.89 (0.10) |
| Overhydration (L)* | 0.82 (1.70) |
| Mean 24 hour systolic blood pressure (mm Hg)** | 138.9 (18.5) |
| Mean 24 hour diastolic blood pressure (mm Hg)** | 77.9 (8.6) |
| Antihypertensive therapy. Patients treated (%) | 110 (91.7) |
| Antihypertensive therapy. Number of drugs per patient | 2.3 (3.7) |
| RAA antagonists (%) | 61 (50.8) |
| Statin therapy (%) | 90 (75.0) |
| Allopurinol/Febuxostat (%) | 52 (42.5) |
| Loop diuretics (%) | 52 (42.5) |
| Antiplatelet drugs (%) | 57 (47.5) |
| EPO therapy (%) | 17 (14.2) |
*Multifrequency bioimpedance analysis.
**24-hour ambulatory pressure record.
Figures denote mean values (standard deviation)(numeric variables) or n (%)(categorized variables). RAA: Renin-angiotensin axis.